Antimetastatic activity of honokiol in osteosarcoma

Cancer

Volumn 118, Issue 8, 2012, Pages 2117-2127

  Steinmann, Patrick ^a   Walters, Denise K ^a   Arlt, Matthias J E ^a   Banke, Ingo J ^a   Ziegler, Urs ^a   Langsam, Bettina ^a   Arbiser, Jack ^b,c   Muff, Roman ^a   Born, Walter ^a   Fuchs, Bruno ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

cytotoxicity; honokiol; metastasis; osteosarcoma

Indexed keywords

BETA GALACTOSIDASE; CYCLOSPORIN A; HONOKIOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CANCER INHIBITION; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SWELLING; CELL VACUOLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DRUG CYTOTOXICITY; ENDOPLASMIC RETICULUM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; LUNG METASTASIS; METABOLIC INHIBITION; METASTASIS INHIBITION; METASTASIS POTENTIAL; MITOCHONDRION; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; TUMOR GROWTH; WOUND HEALING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIPHENYL COMPOUNDS; BONE NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; LIGNANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MICE; MICE, INBRED C3H; OSTEOSARCOMA;

EID: 84859640485     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26434     Document Type: Article

References (32)

1. Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G,. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev. 2006; 32: 423-436.
2. Marina N, Gebhardt M, Teot L, Gorlick R,. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 2004; 9: 422-441.
3. Tsai SK, Huang CH, Huang SS, Hung LM, Hong CY,. Antiarrhythmic effect of magnolol and honokiol during acute phase of coronary occlusion in anesthetized rats: influence of L-NAME and aspirin. Pharmacology. 1999; 59: 227-233.
4. Tsai SK, Huang SS, Hong CY,. Myocardial protective effect of honokiol: an active component in Magnolia officinalis. Planta Med. 1996; 62: 503-506.
5. Ho KY, Tsai CC, Chen CP, Huang JS, Lin CC,. Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis. Phytother Res. 2001; 15: 139-141.
6. Chiang CK, Sheu ML, Hung KY, Wu KD, Liu SH,. Honokiol, a small molecular weight natural product, alleviates experimental mesangial proliferative glomerulonephritis. Kidney Int. 2006; 70: 682-689.
7. Ou HC, Chou FP, Lin TM, Yang CH, Sheu WH,. Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells. Chem Biol Interact. 2006; 161: 1-13.
8. Bai X, Cerimele F, Ushio-Fukai M, et al. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem. 2003; 278: 35501-35507.
9. Ishitsuka K, Hideshima T, Hamasaki M, et al. Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis. Blood. 2005; 106: 1794-1800.
10. Nagase H, Ikeda K, Sakai Y,. Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080. Invasiveness in vitro. Planta Med. 2001; 67: 705-708.
11. Battle TE, Arbiser J, Frank DA,. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood. 2005; 106: 690-697.
12. Hibasami H, Achiwa Y, Katsuzaki H, et al. Honokiol induces apoptosis in human lymphoid leukemia Molt 4B cells. Int J Mol Med. 1998; 2: 671-673.
13. Yang SE, Hsieh MT, Tsai TH, Hsu SL,. Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells. Biochem Pharmacol. 2002; 63: 1641-1651.
14. Chen F, Wang T, Wu YF, et al. Honokiol: a potent chemotherapy candidate for human colorectal carcinoma. World J Gastroenterol. 2004; 10: 3459-3463.
15. Wang T, Chen F, Chen Z, et al. Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol. 2004; 10: 2205-2208.
16. Shigemura K, Arbiser JL, Sun SY, et al. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer. 2007; 109: 1279-1289.
17. Wolf I, O'Kelly J, Wakimoto N, et al. Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest. Int J Oncol. 2007; 30: 1529-1537.
18. Sheu ML, Liu SH, Lan KH,. Honokiol induces calpain-mediated glucose-regulated protein-94 cleavage and apoptosis in human gastric cancer cells and reduces tumor growth [serial online]. PLoS ONE. 2007; 2: e1096.
19. Kuribara H, Kishi E, Hattori N, Okada M, Maruyama Y,. The anxiolytic effect of 2 oriental herbal drugs in Japan attributed to honokiol from magnolia bark. J Pharm Pharmacol. 2000; 52: 1425-1429.
20. Kuribara H, Stavinoha WB, Maruyama Y,. Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice. J Pharm Pharmacol. 1998; 50: 819-826.
21. Mitta B, Rimann M, Fussenegger M,. Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particles. Metab Eng. 2005; 7: 426-436.
22. Asai T, Ueda T, Itoh K, et al. Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer. 1998; 76: 418-422.
23. Arlt MJ, Banke IJ, Walters DK, et al. LacZ transgene expression in the subcutaneous Dunn/LM8 osteosarcoma mouse model allows for the identification of micrometastasis. J Orthop Res. 2011; 29: 938-946.
24. Fidler IJ, Kripke ML,. Metastasis results from preexisting variant cells within a malignant tumor. Science. 1977; 197: 893-895.
25. Chen G, Izzo J, Demizu Y, et al. Different redox states in malignant and nonmalignant esophageal epithelial cells and differential cytotoxic responses to bile acid and honokiol. Antioxid Redox Signal. 2009; 11: 1083-1095.
26. Li L, Han W, Gu Y, et al. Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore. Cancer Res. 2007; 67: 4894-4903.
27. Wang Y, Yang Z, Zhao X,. Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells. Toxicol Mech Methods. 2010; 20: 234-241.
28. Urist MR, Nakata N, Felser JM, et al. An osteosarcoma cell and matrix retained morphogen for normal bone formation. Clin Orthop Relat Res. 1977; 124: 251-266.
29. Kishida Y, Yoshikawa H, Myoui A,. Parthenolide, a natural inhibitor of nuclear factor-kappaB, inhibits lung colonization of murine osteosarcoma cells. Clin Cancer Res. 2007; 13: 59-67.
30. Wang X, Duan X, Yang G, et al. Honokiol Crosses BBB and BCSFB, and Inhibits Brain Tumor Growth in Rat 9L Intracerebral Gliosarcoma Model and Human U251 Xenograft Glioma Model. PLoS One. 2011; 6: e18490.
31. Walters DK, Steinmann P, Langsam B, Schmutz S, Born W, Fuchs B,. Identification of potential chemoresistance genes in osteosarcoma. Anticancer Res. 2008; 28: 673-679.
32. Fried LE, Arbiser JL,. Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid Redox Signal. 2009; 11: 1139-1148.